Amicus Therapeutics (FOLD) had the highest return between May 10, 2017 and August 31, 2017 by a mid-cap US stock, returning 109%.
| ASSET | DATE | % RETURN |
|---|---|---|
Amicus Therapeutics (FOLD) | 5/10/2017 - 8/31/2017 | 109% |
Immunitybio (IBRX) | 5/10/2017 - 8/31/2017 | 96.53% |
Appian (APPN) | 5/10/2017 - 8/31/2017 | 90.75% |
Option Care Health (OPCH) | 5/10/2017 - 8/31/2017 | 81.44% |
PTC Therapeutics (PTCT) | 5/10/2017 - 8/31/2017 | 76% |
Autohome (ATHM) | 5/10/2017 - 8/31/2017 | 73.89% |
Constellium (CSTM) | 5/10/2017 - 8/31/2017 | 71.21% |
RadNet (RDNT) | 5/10/2017 - 8/31/2017 | 70.83% |
Skyline (SKY) | 5/10/2017 - 8/31/2017 | 70.19% |
Uniqure (QURE) | 5/10/2017 - 8/31/2017 | 67.22% |
IAMGold (IAG) | 5/10/2017 - 8/31/2017 | 66.83% |
Weibo (WB) | 5/10/2017 - 8/31/2017 | 65.44% |
Arrowhead Pharmaceuticals (ARWR) | 5/10/2017 - 8/31/2017 | 64.71% |
Corcept Therapeutics (CORT) | 5/10/2017 - 8/31/2017 | 63.11% |
Warrior Met Coal (HCC) | 5/10/2017 - 8/31/2017 | 61.88% |
Protagonist Therapeutics (PTGX) | 5/10/2017 - 8/31/2017 | 60.1% |
SolarEdge Technologies (SEDG) | 5/10/2017 - 8/31/2017 | 59.23% |
Light & Wonder (LNW) | 5/10/2017 - 8/31/2017 | 56.1% |
Catalyst Pharmaceuticals (CPRX) | 5/10/2017 - 8/31/2017 | 53.63% |
Appfolio (APPF) | 5/10/2017 - 8/31/2017 | 53.49% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 5/10/2017 - 8/31/2017 | 53% |
Hudbay Minerals (HBM) | 5/10/2017 - 8/31/2017 | 52.63% |
Intellia Therapeutics (NTLA) | 5/10/2017 - 8/31/2017 | 51.73% |
Century Aluminum (CENX) | 5/10/2017 - 8/31/2017 | 51.44% |
TAL Education (TAL) | 5/10/2017 - 8/31/2017 | 48.26% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
